Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/05/2012EP2493315A1 Dimethyl sulfoxide (dmso) or dmso and methylsulfonylmethane (msm) formulations to treat infectious diseases
09/05/2012EP2493314A1 Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis
09/05/2012EP2493313A1 Kinase inhibitors
09/05/2012EP2493312A1 Solid pharmaceutical compositions containing an integrase inhibitor
09/05/2012EP2493310A1 Benzimidazoles as fatty acid synthase inhibitors
09/05/2012EP2493309A1 Methods of treating or preventing acute erythema
09/05/2012EP2493308A1 Aryl aminopyridine pde10 inhibitors
09/05/2012EP2493305A1 2-aminoindole compounds and methods for the treatment of malaria
09/05/2012EP2493304A1 Spirolactam derivatives and uses of same
09/05/2012EP2493303A1 2- [1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA [F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
09/05/2012EP2493302A1 Hexahydrocyclopentyl[f]indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
09/05/2012EP2493299A1 Tertiary amide orexin receptor antagonists
09/05/2012EP2493298A1 The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders
09/05/2012EP2493297A1 Heterocycle amide t-type calcium channel antagonists
09/05/2012EP2493296A1 Alleviating oxidative stress disorders with pufa derivatives
09/05/2012EP2493295A1 Methods to mitigate injury from radiation exposure
09/05/2012EP2493293A1 Methods for maintaining eye health and ameliorating opthalmic maladies in canines
09/05/2012CN1980656B New pharmaceutical use of lipase inhibitor
09/05/2012CN1977052B Double-chain molecule and vector related with KIF 11 gene
09/05/2012CN1960994B Process for preparing oxycodone hydrochloride having 14-hydroxycodeinone less than 25 ppm
09/05/2012CN1955170B Class I tanshinone II A derivative and its application in pharmacy
09/05/2012CN1925866B Treatment of bacterial infections
09/05/2012CN1918148B Substituted benzimidazoles and their use for inducing apoptosis
09/05/2012CN1853666B Pharmaceutical, nutraceutical, dietetic and nutritional compositions based on vegetable fibres
09/05/2012CN1813785B Method for preparing clindamycin hydrochloride powder for injection
09/05/2012CN1798558B Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
09/05/2012CN1794986B Novel medicine for the treatment of cancer
09/05/2012CN1738828B Avermectin b1 and avermectin b1 monosaccharide derivatives having an alkoxymethyl substituent in the 4''- or 4'-position
09/05/2012CN1694710B Pharmaceutical application of 15- or 16- substituted testosterone analogues
09/05/2012CN1679934B Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
09/05/2012CN1636572B Compositions and methods for treatment of mitochondrial diseases
09/05/2012CN1635909B Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
09/05/2012CN1526023B Use of primer and probe of aldose reductase gene in preparing composition for determination of risk factors for cataract
09/05/2012CN1514729B Sustained-release analgesic compounds
09/05/2012CN1165483B Compositions of ciplatin in comination with 2,2'-dithio-bis (ethanesulfonate) (dinesna)
09/05/2012CN102656268A Development of universal cancer drugs and vaccines
09/05/2012CN102656189A Antibodies against human respiratory syncytial virus (RSV) and methods of use
09/05/2012CN102656181A Triterpene derivative, and prophylactic or therapeutic agent for chronic hepatitis C
09/05/2012CN102656180A Lupeol-type triterpene derivatives as antivirals
09/05/2012CN102656179A Bufalin derivatives, pharmaceutical compositions and use thereof
09/05/2012CN102656177A Process for preparation of spiroketal derivative
09/05/2012CN102656175A Crystalline forms of prasugrel salts
09/05/2012CN102656174A Compounds for the treatment of hepatitis C
09/05/2012CN102656173A Inhibitors of Bruton's tyrosine kinase
09/05/2012CN102656172A 8-oxodihydropurine derivative
09/05/2012CN102656171A Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
09/05/2012CN102656168A Polycyclic compounds as lysophosphatidic acid receptor antagonists
09/05/2012CN102656167A Hiv integrase inhibitors
09/05/2012CN102656165A Glycoside derivatives and uses thereof
09/05/2012CN102656164A Pyrimidine compounds as tuberculosis inhibitors
09/05/2012CN102656163A Heterocyclic compounds for the inhibition of PASK
09/05/2012CN102656162A Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
09/05/2012CN102656161A 2,6-diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
09/05/2012CN102656160A Benzimidazole analogues for the treatment or prevention of flavivirus infections
09/05/2012CN102656159A Cgrp receptor antagonists
09/05/2012CN102656158A Novel heterocyclic acrylamides and their use as pharmaceuticals
09/05/2012CN102656157A Pyrrolidine derivatives as NK-3 receptor antagonists
09/05/2012CN102656153A Novel vascular leak inhibitor
09/05/2012CN102656151A Substituted heterocyclic derivatives for the treatment of pain and epilepsy
09/05/2012CN102656149A Benzamide compound
09/05/2012CN102656148A Cyclic hydroxylamine derivatives, their preparation and use as antioxidants
09/05/2012CN102656147A Spiro indole-cyclopropane indolinones useful as AMPK modulators
09/05/2012CN102656145A Modulators of G protein-coupled receptor 88
09/05/2012CN102656144A Inorganic salt complexes of vildagliptin
09/05/2012CN102656142A Substituted benzosulphonamides
09/05/2012CN102656141A Hematopoietic growth factor mimetic small molecule compounds and their uses
09/05/2012CN102656140A 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
09/05/2012CN102656134A Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same
09/05/2012CN102656133A Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same
09/05/2012CN102655911A Use of ferroquine in the treatment or prevention of malaria
09/05/2012CN102655910A Use of the combination of teriflunomide and glatiramer acetate for treating multiple sclerosis
09/05/2012CN102655881A Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
09/05/2012CN102655876A Composition, method, and kit for alpha-1 proteinase inhibitor
09/05/2012CN102655873A Combinations of a specific HCV NS5A inhibitor and an HCV NS3 protease inhibitor
09/05/2012CN102655871A Infectious clones of Torque teno virus
09/05/2012CN102655870A Veterinary pharmaceutical composition and method (alternatives) for the prophylaxis and treatment of diseases of the gastrointestinal tract and intoxications of diverse etiology in animals
09/05/2012CN102655869A Vitamin D3 and analogs thereof for treating alopecia
09/05/2012CN102655868A Combination preparations comprising a cytokine antagonist and corticosteroid
09/05/2012CN102655867A Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome
09/05/2012CN102655866A Therapeutic or prophylactic agent for diabetes
09/05/2012CN102655865A Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyridyl)-1-[2-[4-pyridyl)ethyl]propanamide and uses thereof
09/05/2012CN102655864A Compositions and methods for treating centrally mediated nausea and vomiting
09/05/2012CN102655863A Heparanase activity inhibitor
09/05/2012CN102655862A Composition for lowering blood uric acid level
09/05/2012CN102655861A Combination for the treatment of radiation- or chemotherapy-induced mucositis
09/05/2012CN102655860A Emesis treatment
09/05/2012CN102655859A Combination therapy treatment for viral infections
09/05/2012CN102655858A ABT-263 capsule
09/05/2012CN102655857A Rapidly soluble solid pharmaceutical preparations containing amphiphilic copolymers based on polyethers in combination with hydrophilic polymers
09/05/2012CN102655856A Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them
09/05/2012CN102655855A Antibiotic microparticles for inhalation
09/05/2012CN102655854A Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
09/05/2012CN102655768A Microbially-stable Vitamin E solutions
09/05/2012CN102655753A Combination
09/05/2012CN102655752A Solid pharmaceutical compositions containing an integrase inhibitor
09/05/2012CN102655747A Novel compositions for preventing and/or treating degenerative disorders of the central nervous system
09/05/2012CN102655746A Iminosugars and methods of treating viral diseases
09/05/2012CN102655745A Use of anti-bacterial agents for the treatment of epithelial-related conditions
09/05/2012CN102653568A Herba taraxaci homogeneous polysaccharide and preparation method and application thereof
09/05/2012CN102653548A Targeted antineoplastic compound and preparation method and application thereof
1 ... 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 ... 7860